 Peter Kennealey
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 9 | 2025 | 655 | 1.470 |
Why?
| | Kidney Failure, Chronic | 7 | 2025 | 586 | 1.210 |
Why?
| | Thrombelastography | 4 | 2023 | 158 | 0.870 |
Why?
| | Tissue Plasminogen Activator | 2 | 2023 | 229 | 0.760 |
Why?
| | Pancreas Transplantation | 2 | 2018 | 66 | 0.700 |
Why?
| | Organ Transplantation | 5 | 2023 | 241 | 0.690 |
Why?
| | Blood Coagulation | 2 | 2023 | 262 | 0.620 |
Why?
| | Liver Transplantation | 5 | 2024 | 749 | 0.580 |
Why?
| | Carotid Arteries | 1 | 2019 | 195 | 0.570 |
Why?
| | HLA Antigens | 1 | 2019 | 233 | 0.570 |
Why?
| | Renal Dialysis | 3 | 2023 | 456 | 0.570 |
Why?
| | Simulation Training | 1 | 2018 | 110 | 0.490 |
Why?
| | General Surgery | 1 | 2018 | 176 | 0.480 |
Why?
| | Vascular Surgical Procedures | 1 | 2018 | 325 | 0.450 |
Why?
| | Gastrectomy | 2 | 2025 | 132 | 0.420 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 496 | 0.410 |
Why?
| | Peritoneal Dialysis | 2 | 2024 | 96 | 0.380 |
Why?
| | Tissue and Organ Procurement | 4 | 2024 | 307 | 0.380 |
Why?
| | Obesity, Morbid | 2 | 2025 | 271 | 0.350 |
Why?
| | Clinical Competence | 1 | 2018 | 1149 | 0.320 |
Why?
| | Resuscitation | 2 | 2024 | 275 | 0.320 |
Why?
| | Hernia, Ventral | 1 | 2009 | 24 | 0.300 |
Why?
| | Graft Survival | 5 | 2018 | 491 | 0.300 |
Why?
| | Health Services Accessibility | 2 | 2025 | 989 | 0.270 |
Why?
| | Catheters, Indwelling | 2 | 2024 | 90 | 0.250 |
Why?
| | Living Donors | 3 | 2021 | 267 | 0.250 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2025 | 7 | 0.230 |
Why?
| | Tissue Donors | 3 | 2024 | 395 | 0.220 |
Why?
| | Laparoscopy | 3 | 2024 | 454 | 0.220 |
Why?
| | Informed Consent | 1 | 2024 | 188 | 0.190 |
Why?
| | Middle Aged | 12 | 2025 | 33604 | 0.190 |
Why?
| | Directed Tissue Donation | 1 | 2021 | 5 | 0.180 |
Why?
| | Cardiovascular System | 1 | 2023 | 136 | 0.180 |
Why?
| | Female | 18 | 2025 | 73763 | 0.170 |
Why?
| | Male | 16 | 2025 | 68260 | 0.170 |
Why?
| | Humans | 29 | 2025 | 138651 | 0.170 |
Why?
| | Reperfusion | 1 | 2020 | 44 | 0.170 |
Why?
| | Feasibility Studies | 1 | 2024 | 980 | 0.160 |
Why?
| | Kidney Function Tests | 1 | 2020 | 156 | 0.160 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 49 | 0.160 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 90 | 0.160 |
Why?
| | Postoperative Period | 1 | 2020 | 355 | 0.150 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 176 | 0.140 |
Why?
| | Registries | 2 | 2024 | 2073 | 0.140 |
Why?
| | Prospective Studies | 4 | 2020 | 7554 | 0.140 |
Why?
| | Adult | 10 | 2024 | 38201 | 0.140 |
Why?
| | Predictive Value of Tests | 2 | 2020 | 2030 | 0.140 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 158 | 0.130 |
Why?
| | Transplantation, Homologous | 1 | 2018 | 406 | 0.130 |
Why?
| | Cattle | 1 | 2019 | 991 | 0.130 |
Why?
| | Family | 1 | 2021 | 677 | 0.130 |
Why?
| | Death | 2 | 2023 | 125 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 613 | 0.120 |
Why?
| | Retrospective Studies | 7 | 2024 | 15909 | 0.110 |
Why?
| | Diabetes Complications | 1 | 2016 | 223 | 0.110 |
Why?
| | Obesity | 2 | 2025 | 2962 | 0.110 |
Why?
| | Markov Chains | 2 | 2025 | 126 | 0.110 |
Why?
| | Diabetic Nephropathies | 1 | 2018 | 299 | 0.110 |
Why?
| | Treatment Outcome | 6 | 2024 | 10923 | 0.110 |
Why?
| | Aged | 6 | 2024 | 24024 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2024 | 2722 | 0.100 |
Why?
| | Catheterization | 2 | 2024 | 181 | 0.100 |
Why?
| | Polytetrafluoroethylene | 1 | 2011 | 25 | 0.090 |
Why?
| | Vascular Patency | 1 | 2011 | 109 | 0.090 |
Why?
| | Decision Support Techniques | 2 | 2025 | 427 | 0.090 |
Why?
| | Protons | 1 | 2011 | 92 | 0.080 |
Why?
| | Fibrinolysis | 2 | 2023 | 147 | 0.080 |
Why?
| | Brain Death | 1 | 2010 | 46 | 0.080 |
Why?
| | Flavonoids | 2 | 2011 | 85 | 0.080 |
Why?
| | Blood Vessel Prosthesis | 1 | 2011 | 138 | 0.080 |
Why?
| | Prognosis | 1 | 2018 | 3984 | 0.080 |
Why?
| | Waiting Lists | 2 | 2021 | 241 | 0.080 |
Why?
| | Weight Loss | 2 | 2025 | 783 | 0.080 |
Why?
| | Piperidines | 2 | 2011 | 216 | 0.070 |
Why?
| | Surgical Mesh | 1 | 2009 | 52 | 0.070 |
Why?
| | United States | 5 | 2024 | 14938 | 0.070 |
Why?
| | Nephrectomy | 1 | 2009 | 155 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 870 | 0.070 |
Why?
| | Internship and Residency | 1 | 2018 | 1187 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7677 | 0.070 |
Why?
| | Biocompatible Materials | 1 | 2011 | 425 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2006 | 67 | 0.060 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2006 | 38 | 0.060 |
Why?
| | Apoptosis | 3 | 2011 | 2546 | 0.060 |
Why?
| | Creatinine | 2 | 2023 | 486 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 5803 | 0.060 |
Why?
| | Colorectal Neoplasms | 1 | 2011 | 777 | 0.050 |
Why?
| | Abdomen | 1 | 2024 | 135 | 0.050 |
Why?
| | Young Adult | 1 | 2019 | 13305 | 0.050 |
Why?
| | Canada | 1 | 2024 | 407 | 0.050 |
Why?
| | Abdominal Pain | 1 | 2024 | 142 | 0.050 |
Why?
| | Platelet Count | 1 | 2022 | 85 | 0.050 |
Why?
| | Organ Preservation | 1 | 2023 | 107 | 0.050 |
Why?
| | Platelet Transfusion | 1 | 2022 | 72 | 0.050 |
Why?
| | Perfusion | 1 | 2023 | 225 | 0.050 |
Why?
| | Patients | 1 | 2023 | 180 | 0.040 |
Why?
| | Bariatric Surgery | 1 | 2025 | 217 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3706 | 0.040 |
Why?
| | Altruism | 1 | 2021 | 26 | 0.040 |
Why?
| | Kidney | 1 | 2009 | 1466 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2020 | 67 | 0.040 |
Why?
| | Computer Systems | 1 | 2020 | 51 | 0.040 |
Why?
| | Viscosity | 1 | 2020 | 92 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2020 | 104 | 0.040 |
Why?
| | Adolescent | 1 | 2019 | 21564 | 0.040 |
Why?
| | Patient Selection | 2 | 2016 | 676 | 0.040 |
Why?
| | Animals | 2 | 2019 | 37217 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2011 | 2152 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 427 | 0.040 |
Why?
| | Survival Rate | 2 | 2016 | 1935 | 0.040 |
Why?
| | Aging | 1 | 2008 | 1855 | 0.040 |
Why?
| | Critical Care | 1 | 2023 | 640 | 0.030 |
Why?
| | Body Mass Index | 1 | 2025 | 2349 | 0.030 |
Why?
| | Teratocarcinoma | 1 | 1995 | 2 | 0.030 |
Why?
| | Time Factors | 2 | 2020 | 6851 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1641 | 0.020 |
Why?
| | Cell Cycle | 2 | 2011 | 592 | 0.020 |
Why?
| | Choline Kinase | 1 | 2011 | 3 | 0.020 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2011 | 3 | 0.020 |
Why?
| | Phosphorus Isotopes | 1 | 2011 | 8 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5697 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2011 | 80 | 0.020 |
Why?
| | Camptothecin | 1 | 2011 | 122 | 0.020 |
Why?
| | Neoplasms | 1 | 2004 | 2681 | 0.020 |
Why?
| | Angiography | 1 | 2009 | 207 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2011 | 553 | 0.020 |
Why?
| | Imatinib Mesylate | 1 | 2006 | 80 | 0.020 |
Why?
| | Graft Rejection | 1 | 2008 | 536 | 0.010 |
Why?
| | Brain Injuries | 1 | 2010 | 501 | 0.010 |
Why?
| | Benzamides | 1 | 2006 | 213 | 0.010 |
Why?
| | Body Water | 1 | 2004 | 23 | 0.010 |
Why?
| | Hydrogen | 1 | 2004 | 75 | 0.010 |
Why?
| | Down-Regulation | 1 | 2006 | 635 | 0.010 |
Why?
| | Piperazines | 1 | 2006 | 345 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 2006 | 325 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2004 | 956 | 0.010 |
Why?
| | Pyrimidines | 1 | 2006 | 472 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 1742 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1760 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1233 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1470 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5112 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3392 | 0.010 |
Why?
| | Genes, p53 | 1 | 1995 | 67 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1995 | 142 | 0.010 |
Why?
| | Mice | 1 | 2011 | 17814 | 0.010 |
Why?
| | Cell Survival | 1 | 1995 | 1123 | 0.010 |
Why?
|
|
Kennealey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|